Anti-LMBRD2 antibodies are used in the immunodetection of the protein LMBR1 domain containing 2. In humans, the canonical protein has a reported length of 695 amino acid residues and a mass of 81.2 kDa. Its subcellular localization is in the cell membrane. It is notably widely expressed in many tissue types. It is a member of the LIMR protein family. Post-translational modifications have been described, including glycosylation. The LMBRD2 gene has been associated with the disease, Developmental delay with variable neurologic and brain abnormalities. Synonyms for this target antigen include G-protein coupled receptor-associated protein LMBRD2 and LMBR1 domain-containing protein 2. LMBRD2 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Immunocytochemistry, Immunofluorescence, and Immunohistochemistry are common applications for LMBRD2 antibodies.